Analysis of prognostic markers in serous ovarian cancer following neoadjuvant chemotherapy

被引:0
|
作者
Mathur, S. R. [1 ]
Khandakar, B. [1 ]
Kumar, L. [2 ]
Kumar, S. [3 ]
Iyer, V. K. [1 ]
Gupta, S. Datta [1 ]
机构
[1] AIIMS, Dept Pathol, New Delhi, India
[2] AIIMS, Dept Med Oncol, New Delhi, India
[3] AIIMS, Dept Obstet & Gynaecol, New Delhi, India
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
306
引用
收藏
页码:106 / 107
页数:2
相关论文
共 50 条
  • [1] Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
    Khandakar, Binny
    Mathur, Sandeep R.
    Kumar, Lalit
    Kumar, Sunesh
    Gupta, Siddhartha Datta
    Iyer, Venkateswaran K.
    Kalaivani, M.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [2] Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
    Chauhan, Sonali
    Shrivastava, Deepti
    Dhande, Rajasbala
    Deo, Asawari
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [3] Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy
    Liontos, Michalis
    Sotiropoulou, Maria
    Kaparelou, Maria
    Tzannis, Kimon
    Tsironis, George
    Kyriazoglou, Anastasios
    Tsiara, Anna
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Zagouri, Flora
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    GYNECOLOGIC ONCOLOGY, 2020, 157 (03) : 599 - 605
  • [4] Prognostic markers in neoadjuvant chemotherapy
    Green, L
    Rayter, Z
    Calder, C
    Fardon, JR
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S107 - S108
  • [5] Evaluation of chemotherapy response score and lymphocytic infiltration as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Koutsoukos, K.
    Zagouri, F.
    Vlachos, D.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Dimopoulos, M. A. C.
    Bamias, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
    Huo, Chuying
    Wu, Bin
    Ye, Dongdong
    Xu, Miaochun
    Ma, Shaolin
    Cheng, Aoshuang
    Liu, Yunyun
    Huang, Chunxian
    Zhang, Yuhao
    Lin, Zhongqiu
    Li, Bowen
    Lu, Huaiwu
    BMC CANCER, 2024, 24 (01)
  • [7] The Prognostic Role of Histopathological Tumour Response Following Neoadjuvant Chemotherapy in High Grade Serous Tubo-Ovarian Carcinoma
    Coghlan, E.
    Munro, A.
    Bulsara, M.
    Magee, D.
    Stewart, C.
    Tang, A.
    Koay, E.
    Cohen, P.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2016, 56 : 22 - 22
  • [8] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    M. Liontos
    A. Andrikopoulou
    K. Koutsoukos
    C. Markellos
    E. Skafida
    O. Fiste
    M. Kaparelou
    N. Thomakos
    D. Haidopoulos
    A. Rodolakis
    M. A. Dimopoulos
    F. Zagouri
    Journal of Ovarian Research, 14
  • [9] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Andrikopoulou, A.
    Koutsoukos, K.
    Markellos, C.
    Skafida, E.
    Fiste, O.
    Kaparelou, M.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Dimopoulos, M. A.
    Zagouri, F.
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [10] Oligoclonality following chemotherapy in high grade serous ovarian cancer
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Sakai, Kazuko
    Nishio, Kazuto
    Matsumura, Noriomi
    CANCER SCIENCE, 2018, 109 : 127 - 127